Results
|
|
1.
|
First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation. MedStar authors:
Year: 2014
Citation:
- Obstet Gynecol. 123(3):611-7, 2014 Mar.
- Obstetrics & Gynecology. 123(3):611-7, 2014 Mar.
Institution:
- MedStar Franklin Square Medical Center
- MedStar Harbor Hospital
Department: - Obstetrics and Gynecology
Medline publication type:
- Journal Article
- Multicenter Study
- Observational Study
- Research Support, Non-U.S. Gov't
All authors: - Atlas RO, Baschat AA, Blitzer MG, Block-Abraham DM, Doyle LE, Jenkins CB, Kopelman JN, Turan OM
|
|
|
2.
|
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. MedStar authors:
Citation: - Lancet Oncology. 16(8):957-66, 2015 Aug.
Institution: - MedStar Washington Hospital Center
Department: - Surgery/Colorectal Surgery
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
All authors: - Avila K, Cataldo PA, Chow OS, Coutsoftides T, Dietz DW, Fichera A, Garcia-Aguilar J, Herzig DO, Hunt SR, Kumar AS, Marcet JE, Oommen S, Patil S, Polite BN, Smith DD, Stamos MJ, Ternent CA, Timing of Rectal Cancer Response to Chemoradiation Consortium, Varma MG
|
|
|
3.
|
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(12):1183-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N
|
